Description
A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO cells expressing the human receptor); selective for β2-ARs over β1- and β3-ARs (Kds = 46.8 and 21.9 μM, respectively); reduces acetylcholine-induced bronchospasm in anesthetized guinea pigs (25-50 μg/kg, i.v.); reduces response of bronchial muscle to efferent vagal stimulation in anesthetized cats and dogs (1-2.5 and 10-20 μg/kg, i.v., respectively); reduces transpulmonary pressure in recurrent airway obstruction-affected horses (EC50 = 39.7 μg)
Formal name: α1R-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol, monohydrochloride
Synonyms: (-)-Salbutamol|(R)-Salbutamol|Levalbuterol
Molecular weight: 275.8
CAS: 50293-90-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Cardiovascular Diseases||Research Area|Cardiovascular System|Heart|Arrhythmia||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma||Research Area|Immunology & Inflammation|Pulmonary Diseases|COPD/Emphysema